title: Comparison of percentage fall in FVC at the provocative concentration of methacholine causing a 20% fall in FEV(1) between patients with asymptomatic bronchial hyperresponsiveness and mild asthma.
abstract: BACKGROUND
  A significant proportion of individuals who have no symptoms of asthma or other respiratory diseases show bronchial hyperresponsiveness (BHR). BHR is usually assessed by measuring the provocative concentration of methacholine causing a 20% fall in FEV(1) (PC(20)). The percentage fall in FVC at the PC(20) (DeltaFVC) has been suggested to reflect maximal airway response and to be a more useful index of disease severity in asthma than PC(20). The aim of this study was to investigate whether asymptomatic BHR would differ from symptomatic BHR with regard to DeltaFVC.
  
  
  METHODS
  Methacholine bronchial challenge tests were conducted in children with no past or current symptoms of asthma, allergic rhinitis, or other respiratory diseases, who were identified among siblings of children with asthma. Forty-three children with asymptomatic BHR (PC(20) < 16 mg/mL) were recruited, and 43 children with mild asthma who were matched for age, sex, and PC(20) were selected (mild asthma group). The DeltaFVC on methacholine concentration-response curves was retrospectively analyzed in the two groups.
  
  
  RESULTS
  There were no differences in the frequency of atopy, blood eosinophil counts, serum IgE levels, and spirometric values between the asymptomatic BHR and mild asthma groups. Mean (+/- SD) DeltaFVC was significantly (p = 0.005) lower in the asymptomatic BHR group (14.5 +/- 3.6%) than in the mild asthma group (16.9 +/- 4.3%).
  
  
  CONCLUSIONS
  Our results suggest that children with asymptomatic BHR have a lower level of maximal airway response than mild asthmatics with a similar degree of BHR. This may be a possible explanation for the lack of symptoms in subjects with asymptomatic BHR.
authors.affiliation: Department of Pediatrics, Seoul National University Hospital, 28 Yongon-dong, Chongno-gu, Seoul 110-744, Korea.
authors.forename: Young
authors.initials: Y
authors.lastname: Yoo
authors.forename: Ji Tae
authors.initials: JT
authors.lastname: Choung
authors.forename: Jinho
authors.initials: J
authors.lastname: Yu
authors.forename: Do Kyun
authors.initials: DK
authors.lastname: Kim
authors.forename: Sun Hee
authors.initials: SH
authors.lastname: Choi
authors.forename: Young Yull
authors.initials: YY
authors.lastname: Koh
mesh_terms: D000293:Adolescent; D001249:Asthma / Q000097:blood / Q000473:pathology / Q000503:physiopathology*; D016535:Bronchial Hyperreactivity / Q000097:blood / Q000473:pathology / Q000503:physiopathology*; D001985:Bronchial Provocation Tests / Q000379:methods*; D016085:Bronchoconstrictor Agents / Q000008:administration & dosage; D002648:Child; D004305:Dose-Response Relationship, Drug; D004804:Eosinophils / Q000473:pathology; D005260:Female; D005541:Forced Expiratory Volume / Q000502:physiology*; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D008297:Male; D016210:Methacholine Chloride / Q000008:administration & dosage; D012189:Retrospective Studies; D012720:Severity of Illness Index; D014797:Vital Capacity / Q000502:physiology*
chemical_list: D016085:Bronchoconstrictor Agents; D016210:Methacholine Chloride; D007073:Immunoglobulin E